Generics BV v Smith Kline & French Laboratories Ltd (C-316/95)
law://eu/cjeu/1995/c-316-95/para_15@2026-11-14
Key facts
Court
Court of Justice · Full Court
Case
C-316/95 · ECLI:EU:C:1997:347
Decided
9 Jul 1997
Procedure
Preliminary reference
Applicant
Generics BV
Defendant
Smith Kline & French Laboratories Ltd
Rapporteur
C. Gulmann
Advocate General
F. G. Jacobs
Bench
10 judgesJ. C. Moitinho de Almeida, J. L. Murray, L. Sevón (Presidents of Chambers), P. J. G. Kapteyn, C. Gulmann, D. A. O. Edward, G. Hirsch, P. Jann, H. Ragnemalm, M. Wathelet
15It has consistently been held that any measure capable of hindering, directly or indirectly, actually or potentially, intra-Community trade constitutes a measure having an effect equivalent to a quantitative restriction (Case 8/74Procureur du Roi v Dassonville [1974] ECR 837, paragraph 5, and Case C-412/93Leclerc-Siplec v TF1 Publicité and M6 Publicité [1995] ECR I-179, paragraph 18).